Tags: science, limbic system, cannabis history, cannabis research, endocannabinoid system
Science Keynote, Ethan Russo, MD presents "Cannabis and Psychiatry The Final Frontier" at CannMed 2022.
Cannabis has been utilized throughout history to treat grief, pain, sleep disorders and even mental illness. The discovery of the endocannabinoid system and its critical role in neurotransmission and homeostasis of the limbic system and other brain areas provide a rationale for utilization of properly formulated cannabis-based medicines in treatment of myriad psychiatric conditions. Historical claims will be presented along with basic science and clinical trial data to assess the current future role of cannabis psychopharmacology with respect to issues of impairment, depression, insomnia, PTSD, schizophrenia, anxiety and addiction. Appropriate formulations for cannabis chemovars will be suggested and the most current research on cannabinoid/terpenoid synergy will be highlighted.
